December 27, 2012
Federal drug regulators said that five Arizona doctors and nurse practitioners are among more than 350 practices nationwide that may have received a Canadian drug supplier's shipment of unapproved Botox that could be counterfeit or unsafe.
The Food and Drug Administration said that medical practices should stop using the wrinkle-busting treatment shipped by suppliers owned by Canada Drugs. The FDA said the shipments were unapproved, so the federal agency cannot verify whether the Botox is safe and effective.
Read entire article on AZ Central